Junshan Qiu

3PUBLICATIONS
56CO-AUTHORS
Molecular targetsFlight dynamicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.

Melanie Royce, Mirat Shah, Lijun Zhang

|May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer.

Asma Dilawari, Mirat Shah, Gwynn Ison

|Sep 14, 2022
Bridging of a Liquid Chromatography-Tandem Mass Spectrometry Method for Oxytetracycline, Chlortetracycline, and Tetracycline in Bovine Kidney with the Official Microbial Growth Inhibition Assay.

Lauren Girard, Hui Li, Charles Feng

Pageof 1

Frequent Collaborators

2 joint publications

William F Pierce

2 joint publications

Richard Pazdur

2 joint publications

Shenghui Tang

2 joint publications

Tiffany K Ricks